Susquehanna International Group
AZN icon

Susquehanna International Group’s AstraZeneca AZN Stock Holding History

Susquehanna International Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229M Buy
1,163,100
+608,400
+110% +$117M 0.03% 466
2025
Q4 		$102M Sell
554,700
-177,700
-24% -$31.2M 0.01% 873
2025
Q3 		$112M Buy
732,400
+107,350
+17% +$16.2M 0.01% 812
2025
Q2 		$87.4M Sell
625,050
-138,200
-18% -$19.4M 0.01% 826
2025
Q1 		$112M Buy
763,250
+213,850
+39% +$30.9M 0.02% 603
2024
Q4 		$72M Buy
549,400
+318,900
+138% +$44.6M 0.01% 894
2024
Q3 		$35.9M Buy
230,500
+14,700
+7% +$2.37M 0.01% 1334
2024
Q2 		$33.7M Sell
215,800
-70,700
-25% -$10.6M 0.01% 1264
2024
Q1 		$38.8M Sell
286,500
-232,050
-45% -$30.7M 0.01% 1210
2023
Q4 		$69.8M Sell
518,550
-536,600
-51% -$69.8M 0.01% 859
2023
Q3 		$143M Buy
1,055,150
+438,750
+71% +$59.9M 0.03% 465
2023
Q2 		$88.2M Buy
616,400
+112,900
+22% +$16.6M 0.02% 670
2023
Q1 		$69.9M Sell
503,500
-59,750
-11% -$8.04M 0.01% 763
2022
Q4 		$76.7M Buy
563,250
+97,900
+21% +$12.3M 0.02% 671
2022
Q3 		$51.1M Buy
465,350
+102,800
+28% +$13M 0.01% 785
2022
Q2 		$48.6M Sell
362,550
-427,750
-54% -$56.1M 0.01% 869
2022
Q1 		$106M Sell
790,300
-61,600
-7% -$7.39M 0.02% 635
2021
Q4 		$99.6M Sell
851,900
-459,900
-35% -$54.1M 0.01% 712
2021
Q3 		$158M Buy
1,311,800
+8,650
+0.7% +$1.01M 0.02% 610
2021
Q2 		$157M Sell
1,303,150
-709,900
-35% -$77.9M 0.02% 610
2021
Q1 		$201M Buy
2,013,050
+437,150
+28% +$43.9M 0.03% 443
2020
Q4 		$158M Sell
1,575,900
-74,650
-5% -$7.91M 0.03% 489
2020
Q3 		$181M Buy
1,650,550
+857,350
+108% +$95.4M 0.03% 368
2020
Q2 		$83.9M Buy
793,200
+418,200
+112% +$43.2M 0.02% 576
2020
Q1 		$33.5M Buy
375,000
+55,700
+17% +$5.24M 0.01% 865
2019
Q4 		$31.8M Buy
319,300
+92,100
+41% +$8.67M 0.01% 1084
2019
Q3 		$20.3M Buy
227,200
+38,800
+21% +$3.36M 0.01% 1321
2019
Q2 		$15.6M Sell
188,400
-138,050
-42% -$10.8M 0.01% 1488
2019
Q1 		$26.4M Sell
326,450
-149,550
-31% -$11.8M 0.01% 998
2018
Q4 		$36.2M Sell
476,000
-497,250
-51% -$38.8M 0.01% 724
2018
Q3 		$77M Buy
973,250
+568,450
+140% +$43M 0.03% 523
2018
Q2 		$28.4M Buy
404,800
+37,750
+10% +$2.72M 0.01% 1034
2018
Q1 		$25.7M Sell
367,050
-358,350
-49% -$24.8M 0.01% 1041
2017
Q4 		$50.3M Sell
725,400
-95,300
-12% -$6.43M 0.02% 691
2017
Q3 		$55.6M Sell
820,700
-1,744,550
-68% -$110M 0.02% 589
2017
Q2 		$175M Buy
2,565,250
+1,256,400
+96% +$82M 0.08% 213
2017
Q1 		$81.5M Buy
1,308,850
+716,150
+121% +$41.7M 0.04% 394
2016
Q4 		$32.4M Buy
592,700
+163,400
+38% +$9.28M 0.02% 752
2016
Q3 		$28.2M Buy
429,300
+92,350
+27% +$6.04M 0.01% 800
2016
Q2 		$20.3M Buy
336,950
+88,600
+36% +$5.15M 0.01% 964
2016
Q1 		$14M Sell
248,350
-24,750
-9% -$1.49M 0.01% 1257
2015
Q4 		$18.5M Sell
273,100
-24,400
-8% -$1.6M 0.01% 1200
2015
Q3 		$18.9M Sell
297,500
-241,000
-45% -$15.9M 0.01% 1249
2015
Q2 		$34.3M Buy
538,500
+35,100
+7% +$2.4M 0.01% 907
2015
Q1 		$34.4M Sell
503,400
-3,055,900
-86% -$212M 0.02% 848
2014
Q4 		$251M Buy
3,559,300
+1,726,100
+94% +$124M 0.1% 187
2014
Q3 		$131M Buy
1,833,200
+712,000
+64% +$52.1M 0.05% 333
2014
Q2 		$83.3M Buy
1,121,200
+923,600
+467% +$66.8M 0.04% 439
2014
Q1 		$12.8M Sell
197,600
-194,300
-50% -$12.5M 0.01% 1716
2013
Q4 		$23.3M Sell
391,900
-3,700
-0.9% -$201K 0.01% 1204
2013
Q3 		$20.5M Sell
395,600
-73,400
-16% -$3.69M 0.01% 1192
2013
Q2 		$22.2M Buy
+469,000
New +$23.9M 0.01% 1038

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Susquehanna International Group's AZN Position: Q1 2026 in Review

Susquehanna International Group increased its AstraZeneca (AZN) stake by 816% in Q1 2026, buying an estimated $23.5M and bringing the position to 136,541 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Susquehanna International Group first reported a position in AZN in Q3 2013 and has held it in 48 quarters since. The position peaked at $173M in Q3 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Susquehanna International Group held 136,541 shares of AstraZeneca worth $26.9M as of Q1 2026.
  • Susquehanna International Group bought 121,634 AstraZeneca shares in Q1 2026, an estimated $23.5M.
  • AstraZeneca made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1872 holding.
  • Susquehanna International Group first reported a position in AstraZeneca in Q3 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's AstraZeneca position peaked at $173M in Q3 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.